A detailed history of Isthmus Partners, LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Isthmus Partners, LLC holds 132,047 shares of BLFS stock, worth $3.55 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
132,047
Previous 165,247 20.09%
Holding current value
$3.55 Million
Previous $3.54 Million 6.66%
% of portfolio
0.41%
Previous 0.43%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$19.19 - $26.52 $637,108 - $880,464
-33,200 Reduced 20.09%
132,047 $3.31 Million
Q2 2024

Aug 06, 2024

BUY
$15.14 - $22.99 $639,892 - $971,672
42,265 Added 34.37%
165,247 $3.54 Million
Q1 2024

May 07, 2024

BUY
$15.35 - $18.82 $704,565 - $863,838
45,900 Added 59.55%
122,982 $2.28 Million
Q4 2023

Feb 12, 2024

BUY
$8.99 - $16.86 $81,134 - $152,161
9,025 Added 13.26%
77,082 $1.25 Million
Q3 2023

Nov 14, 2023

BUY
$10.81 - $22.96 $66,708 - $141,686
6,171 Added 9.97%
68,057 $939,000
Q2 2023

Aug 03, 2023

SELL
$17.19 - $24.34 $2,200 - $3,115
-128 Reduced 0.21%
61,886 $1.37 Million
Q1 2023

May 10, 2023

BUY
$17.67 - $26.07 $25,957 - $38,296
1,469 Added 2.43%
62,014 $1.35 Million
Q4 2022

Feb 10, 2023

BUY
$16.95 - $25.07 $4,135 - $6,117
244 Added 0.4%
60,545 $1.1 Million
Q3 2022

Nov 14, 2022

BUY
$14.64 - $26.7 $46,525 - $84,852
3,178 Added 5.56%
60,301 $1.37 Million
Q2 2022

Aug 08, 2022

BUY
$10.54 - $24.2 $60,699 - $139,367
5,759 Added 11.21%
57,123 $789,000
Q1 2022

May 04, 2022

BUY
$20.81 - $37.29 $491,282 - $880,342
23,608 Added 85.06%
51,364 $1.17 Million
Q4 2021

Jan 25, 2022

SELL
$32.99 - $58.55 $1,583 - $2,810
-48 Reduced 0.17%
27,756 $1.03 Million
Q3 2021

Nov 10, 2021

SELL
$42.03 - $60.5 $897,466 - $1.29 Million
-21,353 Reduced 43.44%
27,804 $1.18 Million
Q2 2021

Aug 10, 2021

BUY
$29.51 - $44.62 $767 - $1,160
26 Added 0.05%
49,157 $2.19 Million
Q1 2021

May 17, 2021

SELL
$32.95 - $44.24 $61,550 - $82,640
-1,868 Reduced 3.66%
49,131 $1.77 Million
Q4 2020

Feb 16, 2021

SELL
$27.5 - $45.75 $251,487 - $418,383
-9,145 Reduced 15.21%
50,999 $2.03 Million
Q3 2020

Nov 04, 2020

BUY
$16.04 - $28.94 $49,675 - $89,627
3,097 Added 5.43%
60,144 $1.74 Million
Q2 2020

Aug 10, 2020

BUY
$9.2 - $17.06 $61,014 - $113,141
6,632 Added 13.15%
57,047 $933,000
Q1 2020

May 15, 2020

SELL
$8.36 - $17.03 $25,013 - $50,953
-2,992 Reduced 5.6%
50,415 $479,000
Q4 2019

Feb 07, 2020

BUY
$14.59 - $18.9 $536,912 - $695,520
36,800 Added 221.59%
53,407 $864,000
Q3 2019

Nov 14, 2019

BUY
$15.7 - $20.98 $260,729 - $348,414
16,607 New
16,607 $276,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.15B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Isthmus Partners, LLC Portfolio

Follow Isthmus Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Isthmus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Isthmus Partners, LLC with notifications on news.